ArticleMolecular neurobiology2025
TAT and RVG Co-modified MSC-derived Exosomes-mediated Delivery of microRNA-15b-5p Inhibitor Alleviate Cerebral Ischemia and Reperfusion-induced Neuronal Apoptosis by Promoting HTR2C-ERK Signaling.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Bone marrow-derived mesenchymal stem cells for ischemic stroke: mechanisms, delivery strategies, clinical evidence, and translational challenges.Stem cell research & therapy · 2026Review
- Neuroinflammation after stroke: initiation, amplification and therapeutic prospects.Journal of translational medicine · 2026Review
- Engineering MSC-exosomes for diabetic bone regeneration: from mechanism to delivery.Stem cell research & therapy · 2026Review
- Spatiotemporal dynamics of brain pericytes in ischemic stroke.Journal of neuroinflammation · 2026Review
- Review
- Beyond immunomodulation: mechanisms and synergistic strategies of mesenchymal stem cells in promoting alveolar epithelial and endothelial repair in ARDS.Frontiers in immunology · 2026Review
- Wenyang Zhenshuai Granules inhibits cardiomyocyte apoptosis in chronic heart failure by regulating p38 MAPK signaling pathway through exosomal miR-155.Frontiers in pharmacology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Neuronal apoptosis significantly contributes to brain damage in cerebral ischemia and reperfusion (I/R) injury, posing a serious threat to human health and lacking effective treatment. MicroRNA-15b-5p (miR-15b-5p) was previously reported to be significantly elevated in serum exosomes from ischemia patients and in freshly excised human stroke brain tissue. However, how miR-15b-5p regulates neuronal death in cerebral I/R injury remains elusive. In addition, we propose that encapsulating the miR-15b-5p inhibitor in TAT and RVG co-modified mesenchymal stem cell-derived exosomes (TAT&RVG-Exo + miR-15b-5p inhibitor) could serve as an effective treatment for cerebral I/R injury. This study utilized a mouse model of intraluminal middle cerebral artery occlusion/reperfusion (MCAO/R) and HT22 hippocampal neuronal cells exposed to oxygen-glucose deprivation and reoxygenation (OGD/R) to simulate cerebral I/R injury. The impact of miR-15b-5p on neuronal death in cerebral I/R injury and its underlying mechanisms were investigated through bioinformatic analysis, qRT-PCR, Western blotting, immunofluorescent staining, flow cytometry, luciferase reporter assay, and RNA-Fluorescence in situ hybridization. Exosomes derived from MSCs were isolated and characterized using transmission electron microscopy and nanoparticle flow cytometer. Through surface modification and sonication, TAT-peptide and RVG-peptide co-decorated MSC-Exos carrying miR-15b-5p inhibitor (TAT&RVG-Exo + miR-15b-5p inhibitor) were prepared. The protective effects of TAT&RVG-Exo + miR-15b-5p inhibitor on cerebral I/R injury were evaluated using biodistribution imaging system, TTC staining, Western blotting and immunofluorescent staining. In cerebral I/R injury, both in vivo and in vitro, miR-15b-5p expression was significantly elevated, and its inhibition notably reduced neuronal apoptosis. Our findings indicate that miR-15b-5p enhances OGD/R-induced neuronal apoptosis through the HTR2C-ERK signaling pathway. TAT&RVG-Exo + miR-15b-5p inhibitor demonstrated enhanced ability to traverse the BBB and target the peri-infarct region in cerebral I/R injured mice, exhibiting superior protective effects against cerebral I/R injury. TAT and RVG co-modified MSC-derived exosomes-mediated delivery of microRNA-15b-5p inhibitor alleviate cerebral I/R-induced neuronal apoptosis by promoting HTR2C-ERK signaling, which offers a potentially effective new treatment for cerebral I/R injury.
Indexed as
Identifiers
40711710What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.